Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

China flag China · Delayed Price · Currency is CNY
16.23
-0.01 (-0.06%)
At close: Mar 9, 2026
10.03%
Market Cap 11.25B
Revenue (ttm) 2.81B
Net Income (ttm) 596.27M
Shares Out 693.22M
EPS (ttm) 0.86
PE Ratio 18.95
Forward PE 17.64
Dividend 0.60 (3.69%)
Ex-Dividend Date May 26, 2025
Volume 8,663,498
Average Volume 11,825,152
Open 16.10
Previous Close 16.24
Day's Range 15.97 - 16.27
52-Week Range 14.61 - 21.07
Beta 0.24
RSI 39.34
Earnings Date Apr 27, 2026

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ... [Read more]

Sector Healthcare
Founded 1995
Employees 2,125
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300181
Full Company Profile

Financial Performance

In 2024, SHE:300181's revenue was 2.58 billion, an increase of 32.71% compared to the previous year's 1.94 billion. Earnings were 507.77 million, an increase of 32.60%.

Financial Statements

News

There is no news available yet.